Rod McNeil

Rod McNeil

Rod McNeil

Independent Journalist and Consultant

Latest Contributions

Rod McNeil · 1st August 2014

An eyeful of independence

Rod McNeil · 1st June 2014

NICE drugs: an update on what’s good to go

Rod McNeil · 1st October 2018

Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies

Rod McNeil · 1st February 2019

Advances and developments in medical retina

Rod McNeil · 1st April 2019

Newer generation IOL platforms designed for high-quality visual performance after cataract surgery

Rod McNeil · 1st June 2019

Quality matters in the management of serious eye disorders

Rod McNeil · 1st August 2019

Coming to terms with AI

Rod McNeil · 1st October 2019

Corporate M&A pace gathers momentum

Rod McNeil · 10th October 2019

Management of DMO and PDR in 2019

Rod McNeil · 2nd December 2019

Management of retinal diseases: highlights from the AAO 2019 Retina Subspecialty Day Meeting

Rod McNeil · 5th February 2020

Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease

Rod McNeil · 5th August 2020

Hot debates in medical retina and imaging: Perspectives from the Controversies in Ophthalmology 2020 virtual conference

Prev

1
2
3
4
5

Next